EDGM Edgemode, Inc.
Services-Home Health Care Services · OTC · SEC CIK 1652958 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-48.1%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-534.3%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets588.5%
Debt / equity—
Current ratio0.00x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.11x
Accruals ratio-475.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q3*2026-09-30 | 2026Q2*2026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $0 | $0 | $0 | — | — | — | — | — |
| SG&A expense | $1.10M | $1.32M | $1.29M | $6.33M | $734,255 | $3.26M | $22.12M | $305,773 |
| Operating income | -$1.10M | -$1.32M | -$14.24M | -$11.16M | -$734,255 | -$3.26M | -$22.12M | -$305,772 |
| Interest expense | $1.53M | — | — | — | $5.87M | — | — | — |
| Pretax income | -$1.51M | -$3.31M | -$5.72M | -$10.27M | $10.34M | -$3.83M | -$20.87M | $574,895 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$1.37M | -$3.13M | -$5.65M | -$10.27M | $10.34M | -$3.83M | -$20.87M | $574,895 |
| EBITDA | — | — | — | -$10.89M | -$805,080 | — | — | -$305,772 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | -0.05 | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | -0.05 | — |
| Weighted avg. shares (diluted) | 5.18B | 3.97B | 3.11B | — | 2.61B | 2.12B | 390.69M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $7,135 | $16,710 | $362,662 | $248,367 | $300,428 | $15,801 | $182,061 | $103 |
| Current assets | $27,658 | $35,684 | $386,052 | $267,158 | $396,728 | $208,783 | $195,259 | $1,471 |
| PP&E, net | — | — | — | $0 | $4.05M | $4.15M | — | $0 |
| Total assets | $1.56M | $1.55M | $1.91M | $1.28M | $6.08M | $5.24M | $378,259 | $1,503 |
| Current liabilities | $9.17M | $10.55M | $9.53M | $19.86M | $25.46M | $4.43M | $4.07M | $4.72M |
| Total liabilities | $9.17M | $10.55M | $9.76M | $20.08M | $25.69M | $4.66M | $4.29M | $4.72M |
| Shareholders' equity | -$7.29M | -$8.82M | -$7.78M | -$18.81M | -$19.61M | $581,845 | -$3.92M | -$4.72M |
| Shares outstanding | 6.05B | 4.28B | 3.55B | 3.00B | 2.44B | 2.30B | 390.69M | 390.69M |
| Cash flow statement | ||||||||
| Operating cash flow | -$578,825 | -$609,452 | -$571,920 | -$473,234 | -$308,992 | -$118,345 | $74,858 | -$5,060 |
| Capital expenditure | -$425,500 | $6,500 | $419,000 | $0 | $1 | $47,915 | $0 | $0 |
| Free cash flow | -$153,325 | -$615,952 | -$990,920 | -$473,234 | -$308,993 | -$166,260 | $74,858 | -$5,060 |
| Investing cash flow | -$5,500 | -$6,500 | -$419,000 | -$253,827 | -$260,001 | -$47,915 | -$183,000 | $0 |
| Financing cash flow | $574,750 | $270,000 | $1.11M | $675,000 | $853,620 | $0 | $290,100 | $0 |
| Depreciation & amortization | — | — | — | $272,379 | -$70,825 | — | — | $0 |
| Stock-based compensation | $35,624 | $37,000 | $13.22M | $4.86M | $166,500 | $2.59M | $21.68M | $0 |
Free plan shows the latest 8 periods; Pro shows all 47 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.